1.Yonghao G, Jin X, Jun L, Pumei D, Ying Y, Xiuhong F, Yanyang Z, Wanshen G: An epidemiological serosurvey of hepatitis B virus shows evidence of declining prevalence due to hepatitis B vaccination in central China. International Journal of Infectious Diseases 2015, 40:75–80.
2.Yu R, Fan R, Hou J: Chronic hepatitis B virus infection: epidemiology, prevention, and treatment in China. Front Med 2014, 8(2):135–144.
3.Wang C, Sun J, Zhu B, Larsen S, Yu R, Wu J, Zhao W: Hepatitis B virus infection and related factors in hemodialysis patients in China - systematic review and meta-analysis. Ren Fail 2010, 32(10):1255–1264.
4.Eleftheriadis T, Liakopoulos V, Leivaditis K, et al: Infections in hemodialysis: a concise review. Part II: blood transmitted viral infections.Hippokratia, 2011, 15(2):120–6.
5.Hoofnagle J H, Seeff L B, Bales Z B, et al: Type B Hepatitis after Transfusion with Blood Containing Antibody to Hepatitis B Core Antigen. N Engl J Med, 1978, 298(25):1379–1383.
6.Besharat S, Katoonizadeh A, Moradi A: Potential mutations associated with occult hepatitis B virus status. Hepat Mon 2014, 14(5):e15275.
7.Torbenson M, Thomas DL: Occult hepatitis B. The Lancet Infectious Diseases 2002, 2(8):479–486.
8.Kim H, Kim B-J: Association of preS/S Mutations with Occult Hepatitis B Virus (HBV) Infection in South Korea: Transmission Potential of Distinct Occult HBV Variants. International Journal of Molecular Sciences 2015, 16(12):13595–13609.
9.Wen X, Su H, Wang Y, Pu Z, Gao J, Ji Z, Yuan X, Li X, Zhang W, Zhang L et al: Prevalence and natural course of occult hepatitis B virus infection in residents of 2 communities of Wuwei City, Gansu Province, China. J Viral Hepat 2018, 25(3):281–288.
10.Samal J, Kandpal M, Vivekanandan P: Molecular mechanisms underlying occult hepatitis B virus infection. Clin Microbiol Rev 2012, 25(1):142–163.
11.Abdel-Maksoud NHM, El-Shamy A, Fawzy M, Gomaa HHA, Eltarabilli MMA: Hepatitis B variants among Egyptian patients undergoing hemodialysis. Microbiol Immunol 2019, 63(2):77–84.
12.Eleftheriadis T, Liakopoulos V, Leivaditis K, et al: Infections in hemodialysis: A concise review - part 1: Bacteremia and respiratory infections. Hippokratia, 2011, 15(1):12–17.
13.Kwak MS, Kim YJ: Occult hepatitis B virus infection. World J Hepatol 2014, 6(12):860–869.
14.Lin CL, Kao JH: Natural history of acute and chronic hepatitis B: The role of HBV genotypes and mutants. Best Pract Res Clin Gastroenterol 2017, 31(3):249–255.
15.Candotti D, Grabarczyk P, Ghiazza P, Roig R, Casamitjana N, Iudicone P, Schmidt M, Bird A, Crookes R, Brojer E et al: Characterization of occult hepatitis B virus from blood donors carrying genotype A2 or genotype D strains. J Hepatol 2008, 49(4):537–547.
16.Tong W, Sun L, He J, et al: A novel nucleotide insertion in S gene of hepatitis B virus in a chronic carrier. Virol J, 2010, 7(1):104.
17.Darmawan E, Turyadi, El-Khobar KE, Nursanty NK, Thedja MD, Muljono DH: Seroepidemiology and occult hepatitis B virus infection in young adults in Banjarmasin, Indonesia. J Med Virol 2015, 87(2):199–207.
18.Oliveira MP, Lemes PS, Matos MA, Del-Rios NH, Carneiro MA, Silva AM, Lopes CL, Teles SA, Aires RS, Lago BV et al: Overt and occult hepatitis B virus infection among treatment-naive HIV-infected patients in Brazil. J Med Virol 2016, 88(7):1222–1229.
19.Song EY, Yun YM, Park MH, Seo DH: Prevalence of occult hepatitis B virus infection in a general adult population in Korea. Intervirology 2009, 52(2):57–62.
20.Ababneh NA, Sallam M, Kaddomi D, Attili AM, Bsisu I, Khamees N, Khatib A, Mahafzah A: Patterns of hepatitis B virus S gene escape mutants and reverse transcriptase mutations among genotype D isolates in Jordan. PeerJ 2019, 7:e6583.
21.Salpini R, Colagrossi L, Bellocchi MC, Surdo M, Becker C, Alteri C, Aragri M, Ricciardi A, Armenia D, Pollicita M et al: Hepatitis B surface antigen genetic elements critical for immune escape correlate with hepatitis B virus reactivation upon immunosuppression. Hepatology 2015, 61(3):823–833.
22.Rezaee R, Poorebrahim M, Najafi S, Sadeghi S, Pourdast A, Alavian SM, Alavian SE, Poortahmasebi V: Impacts of the G145R Mutation on the Structure and Immunogenic Activity of the Hepatitis B Surface Antigen: A Computational Analysis. Hepat Mon 2016, 16(7):e39097.
23.Hou J, Wang Z, Cheng J, Lin Y, Lau GK, Sun J, Zhou F, Waters J, Karayiannis P, Luo K: Prevalence of naturally occurring surface gene variants of hepatitis B virus in nonimmunized surface antigen-negative Chinese carriers. Hepatology 2001, 34(5):1027–1034.
24.Shahmoradi S, Yahyapour Y, Mahmoodi M, Alavian SM, Fazeli Z, Jazayeri SM: High prevalence of occult hepatitis B virus infection in children born to HBsAg-positive mothers despite prophylaxis with hepatitis B vaccination and HBIG. J Hepatol 2012, 57(3):515–521.
25.Koyanagi T, Nakamuta M, Sakai H, et al: Analysis of HBs antigen negative variant of hepatitis B virus: unique substitutions, Glu129 to Asp and Gly145 to Ala in the surface antigen gene. Med Sci Monit, 2000, 6(6):1165–1169.
26.Okamoto H, Tsuda F, Sakugawa H, et al: Typing Hepatitis B Virus by Homology in Nucleotide Sequence: Comparison of Surface Antigen Subtypes. J Gen Virol, 1988, 69(10):2575–2583.
27.Sugauchi F, Orito E, Ichida T, Kato H, Sakugawa H, Kakumu S, Ishida T, Chutaputti A, Lai CL, Ueda R et al: Hepatitis B virus of genotype B with or without recombination with genotype C over the precore region plus the core gene. J Virol 2002, 76(12):5985–5992.
28.Inoue J, Ueno Y, Wakui Y, Fukushima K, Kondo Y, Kakazu E, Ninomiya M, Niitsuma H, Shimosegawa T: Enhanced replication of hepatitis B virus with frameshift in the precore region found in fulminant hepatitis patients. J Infect Dis 2011, 204(7):1017–1025.
29.Bruni R, Prosperi M, Marcantonio C, et al: A computational approach to identify point mutations associated with occult hepatitis B: significant mutations affect coding regions but not regulative elements of HBV. Virol J, 2011, 8(1):394–394.
30.Ye X, Li T, Xu X, Du P, Zeng J, Zhu W, Yang B, Li C, Allain JP: Characterisation and follow-up study of occult hepatitis B virus infection in anti-HBc-positive qualified blood donors in southern China. Blood Transfus, 2017, 15(1):6–12.
31.Dumaidi K, Al-Jawabreh A: Prevalence of occult HBV among hemodialysis patients in two districts in the northern part of the West Bank, Palestine. J Med Virol 2014, 86(10):1694–1699.
32.Zuckerman AJ: Effect of hepatitis B virus mutants on efficacy of vaccination. The Lancet 2000, 355(9213):1382–1384.
33.Amini-Bavil-Olyaee S, Vucur M, Luedde T, Trautwein C, Tacke F: Differential impact of immune escape mutations G145R and P120T on the replication of lamivudine-resistant hepatitis B virus e antigen-positive and -negative strains. J Virol 2010, 84(2):1026–1033.
34.Banerjee A, Chandra PK, Datta S, Biswas A, Bhattacharya P, Chakraborty S, Chakrabarti S, Bhattacharya SK, Chakravarty R: Frequency and significance of hepatitis B virus surface gene variant circulating among ‘antiHBc only’ individuals in Eastern India. J Clin Virol 2007, 40(4):312–317.
35.Lada O, Benhamou Y, Poynard T, Thibault V: Coexistence of hepatitis B surface antigen (HBs Ag) and anti-HBs antibodies in chronic hepatitis B virus carriers: influence of “a” determinant variants. J Virol 2006, 80(6):2968–2975.
36.Rastegarvand N, Makvandi M, Samarbafzadeh A, Rasti M, Neisi N, Pouremamali A, Teimoori A, Shabani A: Molecular Characterization of Pre-Core/Core and S Region of Hepatitis B Virus in Hemodialysis Patients With Occult Hepatitis B Infection. Jundishapur J Microbiol 2015, 8(10):e23686.
37.Nainan OV, Khristova ML, Byun K, Xia G, Taylor PE, Stevens CE, Margolis HS: Genetic variation of hepatitis B surface antigen coding region among infants with chronic hepatitis B virus infection. J Med Virol 2002, 68(3):319–327.
38.Wu C, Deng W, Deng L, Cao L, Qin B, Li S, Wang Y, Pei R, Yang D, Lu M et al: Amino acid substitutions at positions 122 and 145 of hepatitis B virus surface antigen (HBsAg) determine the antigenicity and immunogenicity of HBsAg and influence in vivo HBsAg clearance. J Virol 2012, 86(8):4658–4669.